These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 10396970)

  • 1. Closing in on the cause of insulin resistance and type 2 diabetes.
    Brady MJ; Saltiel AR
    J Clin Invest; 1999 Sep; 104(6):675-6. PubMed ID: 10491401
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein kinases as mediators of phosphoinositide 3-kinase signaling.
    Toker A
    Mol Pharmacol; 2000 Apr; 57(4):652-8. PubMed ID: 10727509
    [No Abstract]   [Full Text] [Related]  

  • 3. Ras pathway signals are required for notch-mediated oncogenesis.
    Fitzgerald K; Harrington A; Leder P
    Oncogene; 2000 Aug; 19(37):4191-8. PubMed ID: 10980592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.
    Kandel ES; Hay N
    Exp Cell Res; 1999 Nov; 253(1):210-29. PubMed ID: 10579924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular blueprint for targeting cancer?
    Tlsty TD
    Nat Genet; 1999 Jan; 21(1):64-5. PubMed ID: 9916789
    [No Abstract]   [Full Text] [Related]  

  • 7. The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system.
    Neri LM; Borgatti P; Capitani S; Martelli AM
    Biochim Biophys Acta; 2002 Oct; 1584(2-3):73-80. PubMed ID: 12385889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.
    Krasilnikov MA
    Biochemistry (Mosc); 2000 Jan; 65(1):59-67. PubMed ID: 10702641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the protein kinase B signaling pathway.
    Woodgett JR
    Curr Opin Cell Biol; 2005 Apr; 17(2):150-7. PubMed ID: 15780591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphoinositide 3-kinase].
    Hazeki O
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):961-8. PubMed ID: 10396970
    [No Abstract]   [Full Text] [Related]  

  • 11. [Crosstalk between ceramide and phosphatidylinositol-3 kinase as a mechanism for cell death/survival determination].
    Kondo T; Okazaki T
    Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):442-8. PubMed ID: 11915340
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    J Neurochem; 2005 Jul; 94(1):204-14. PubMed ID: 15953363
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.